These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17910609)

  • 1. Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study.
    Furio AM; Brusco LI; Cardinali DP
    J Pineal Res; 2007 Nov; 43(4):404-9. PubMed ID: 17910609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic application of melatonin in mild cognitive impairment.
    Cardinali DP; Vigo DE; Olivar N; Vidal MF; Furio AM; Brusco LI
    Am J Neurodegener Dis; 2012; 1(3):280-91. PubMed ID: 23383398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease.
    Brusco LI; Márquez M; Cardinali DP
    Neuro Endocrinol Lett; 2000; 21(1):39-42. PubMed ID: 11455329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
    Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
    Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
    Weiss EM; Kohler CG; Vonbank J; Stadelmann E; Kemmler G; Hinterhuber H; Marksteiner J
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):974-80. PubMed ID: 19038896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test.
    Frittelli C; Borghetti D; Iudice G; Bonanni E; Maestri M; Tognoni G; Pasquali L; Iudice A
    Int J Geriatr Psychiatry; 2009 Mar; 24(3):232-8. PubMed ID: 18615781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
    Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
    Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
    Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
    Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.